Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

REPAGLINIDE AND METFORMIN HYDROCHLORIDE

METFORMIN HYDROCHLORIDE; REPAGLINIDE

Standard Dose
500MG;2MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview REPAGLINIDE AND METFORMIN HYDROCHLORIDE is listed in Drugs@FDA under application 200624 (ANDA).

Marketing status: Discontinued Active ingredient METFORMIN HYDROCHLORIDE; REPAGLINIDE Form and strength TABLET;ORAL - 500MG;2MG Sponsor LUPIN LTD Submission history Latest submission status date: 2015-07-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview REPAGLINIDE AND METFORMIN HYDROCHLORIDE is listed in Drugs@FDA under application 200624 (ANDA). Marketing status: Discontinued Active ingredient METFORMIN HYDROCHLORIDE; REPAGLINIDE Form and strength TABLET;ORAL - 500MG;2MG Sponsor LUPIN LTD Submission history Latest submission status date: 2015-07-15 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
REPAGLINIDE AND METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE; REPAGLINIDE) | Drug Monograph | MedicHelpline